StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.25−0.11 (-8.09%)

Close on Nov 20, 2026Market cap $79.66MP/E –Yield –

TuHURA Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

TuHURA Biosciences's price to book ratio was 5.2× on Nov 11, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 0.2× to 13.6×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.2×+2.9
2025Dec 31, 20252.3×+2.1
2024Dec 31, 20240.3×−0.1
2023Dec 29, 20230.4×−0.5
2022Dec 30, 20220.8×+0.0
2021Dec 31, 20210.8×+0.0
2020Dec 31, 20200.8×+0.4
2019Dec 31, 20190.4×+0.3
2018Dec 31, 20180.1×−1.0
2017Dec 29, 20171.1×+0.3
2016Dec 30, 20160.8×–

More TuHURA Biosciences figures

See a number that looks wrong?